122 related articles for article (PubMed ID: 11129080)
1. Simultaneous determination of bosentan and its three major metabolites in various biological matrices and species using narrow bore liquid chromatography with ion spray tandem mass spectrometric detection.
Lausecker B; Hess B; Fischer G; Mueller M; Hopfgartner G
J Chromatogr B Biomed Sci Appl; 2000 Nov; 749(1):67-83. PubMed ID: 11129080
[TBL] [Abstract][Full Text] [Related]
2. Determination of the oral platelet aggregation inhibitor Sibrafiban in rat, dog, and human plasma utilising HPLC-column switching combined with turbo ion spray single quadrupole mass spectrometry.
Timm U; Birnböck H; Erdin R; Hopfgartner G; Zumbrunnen R
J Pharm Biomed Anal; 1999 Oct; 21(1):151-63. PubMed ID: 10701922
[TBL] [Abstract][Full Text] [Related]
3. Column-switching high-performance liquid chromatography combined with ionspray tandem mass spectrometry for the simultaneous determination of the platelet inhibitor Ro 44-3888 and its pro-drug and precursor metabolite in plasma.
Zell M; Husser C; Hopfgartner G
J Mass Spectrom; 1997 Jan; 32(1):23-32. PubMed ID: 9008866
[TBL] [Abstract][Full Text] [Related]
4. Determination of an endothelin receptor antagonist in human plasma by narrow-bore liquid chromatography and ionspray tandem mass spectrometry.
Lausecker B; Hopfgartner G
J Chromatogr A; 1995 Sep; 712(1):75-83. PubMed ID: 8556158
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Determination of Bosentan, Glimepiride, HYBOS and M1 in Rat Plasma by UPLC-MS-MS and its Application to Pharmacokinetic Study.
Chen M; Song W; Wang S; Chen Q; Pan P; Xu T; Hu G; Zheng Z
J Chromatogr Sci; 2016 Aug; 54(7):1159-65. PubMed ID: 27240565
[TBL] [Abstract][Full Text] [Related]
6. A monolithic-phase based on-line extraction approach for determination of pharmaceutical components in human plasma by HPLC-MS/MS and a comparison with liquid-liquid extraction.
Naxing Xu R; Fan L; Kim GE; El-Shourbagy TA
J Pharm Biomed Anal; 2006 Feb; 40(3):728-36. PubMed ID: 16289933
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of a novel KDR kinase inhibitor and its N-oxide metabolite in human plasma using 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry.
Xu Y; Du L; Soli ED; Braun MP; Dean DC; Musson DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):287-96. PubMed ID: 15686997
[TBL] [Abstract][Full Text] [Related]
8. Ultra-fast quantitative bioanalysis of a pharmaceutical compound using liquid chromatography-tandem mass spectrometry.
Heinig K; Bucheli F
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 795(2):337-46. PubMed ID: 14522038
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a fully automated online human dried blood spot analysis of bosentan and its metabolites using the Sample Card And Prep DBS System.
Ganz N; Singrasa M; Nicolas L; Gutierrez M; Dingemanse J; Döbelin W; Glinski M
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():50-60. PubMed ID: 22227055
[TBL] [Abstract][Full Text] [Related]
10. Application of column-switching liquid chromatography-tandem mass spectrometry for the determination of pharmaceutical compounds in tissue samples.
Heinig K; Bucheli F
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Mar; 769(1):9-26. PubMed ID: 11936699
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous measurement of folate cycle intermediates in different biological matrices using liquid chromatography-tandem mass spectrometry.
Nandania J; Kokkonen M; Euro L; Velagapudi V
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():168-178. PubMed ID: 29906678
[TBL] [Abstract][Full Text] [Related]
12. Development of an SPE-LC-MS/MS method for simultaneous quantification of bosentan and its active metabolite hydroxybosentan in human plasma to support a bioequivalence study.
Parekh JM; Shah DK; Sanyal M; Yadav M; Shrivastav PS
J Pharm Biomed Anal; 2012 Nov; 70():462-70. PubMed ID: 22789899
[TBL] [Abstract][Full Text] [Related]
13. Quantitative determination of Orlistat (tetrahydrolipostatin, Ro 18-0647) in human plasma by high-performance liquid chromatography coupled with ion spray tandem mass spectrometry.
Bennett PK; Li YT; Edom R; Henion J
J Mass Spectrom; 1997 Jul; 32(7):739-49. PubMed ID: 9241856
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of UFLC-MS/MS method for determination of bosentan in rat plasma.
Atila A; Ozturk M; Kadioglu Y; Halici Z; Turkan D; Yayla M; Un H
J Pharm Biomed Anal; 2014 Aug; 97():33-8. PubMed ID: 24803031
[TBL] [Abstract][Full Text] [Related]
15. Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry.
Bjørk MK; Nielsen MK; Markussen LØ; Klinke HB; Linnet K
Anal Bioanal Chem; 2010 Apr; 396(7):2393-401. PubMed ID: 19921510
[TBL] [Abstract][Full Text] [Related]
16. Determination of retigabine and its acetyl metabolite in biological matrices by on-line solid-phase extraction (column switching) liquid chromatography with tandem mass spectrometry.
Knebel NG; Grieb S; Leisenheimer S; Locher M
J Chromatogr B Biomed Sci Appl; 2000 Oct; 748(1):97-111. PubMed ID: 11092590
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of bosentan and glimepiride in human plasma by ultra performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study.
Qiu X; Zhao J; Wang Z; Xu Z; Xu RA
J Pharm Biomed Anal; 2014 Jul; 95():207-12. PubMed ID: 24685726
[TBL] [Abstract][Full Text] [Related]
18. High turbulence liquid chromatography online extraction and tandem mass spectrometry for the simultaneous determination of suberoylanilide hydroxamic acid and its two metabolites in human serum.
Du L; Musson DG; Wang AQ
Rapid Commun Mass Spectrom; 2005; 19(13):1779-87. PubMed ID: 15945019
[TBL] [Abstract][Full Text] [Related]
19. Low picogram determination of Ro 48-6791 and its major metabolite, Ro 48-6792, in plasma with column-switching microbore high-performance liquid chromatography coupled to ion spray tandem mass spectrometry.
Zell M; Husser C; Hopfgartner G
Rapid Commun Mass Spectrom; 1997; 11(10):1107-14. PubMed ID: 9218357
[TBL] [Abstract][Full Text] [Related]
20. Development of a liquid chromatographic/tandem mass spectrometric assay for a new endothelin receptor antagonist, and its application to dog plasma samples generated after simultaneous i.v. and p.o. administration of the unlabeled and deuterium-labeled forms of this antagonist.
Lausecker B; Fischer G
J Mass Spectrom; 2003 Jun; 38(6):649-58. PubMed ID: 12827634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
